Use of anti-cgrp or anti-cgrp-r antibodies or antibody fragments to treat or prevent chronic and acute forms of diarrhea

Disclosed the use of an anti-CGRP antibody or anti-CGRP antibody fragment or an anti-CGRP (CGRP-R) receptor antibody or an anti-CGRP-R antibody fragment in the manufacture of a medicament for inhibiting, preventing or treating diarrhea or dysentery and/or maintaining appropriate electrolyte and flui...

Full description

Saved in:
Bibliographic Details
Main Authors Russo, Andrew F, Raddant, Ann C, Recober, Ana, Latham, John A, Smith, Jeffrey T.l, Kovacevich, Brian Robert, Garcia-Martinez, Leon F, Kuburas, Adisa, Kaiser, Eric A
Format Patent
LanguageEnglish
Published 26.08.2022
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:Disclosed the use of an anti-CGRP antibody or anti-CGRP antibody fragment or an anti-CGRP (CGRP-R) receptor antibody or an anti-CGRP-R antibody fragment in the manufacture of a medicament for inhibiting, preventing or treating diarrhea or dysentery and/or maintaining appropriate electrolyte and fluid levels in the colon of a subject having diarrhea or dysentery.
Bibliography:Application Number: NZ20120717704